Here's Why Genetic Testing Stocks Lost as Much as 26.1% in May
Wall Street soured on the high-growth industry after first-quarter earnings were reported, but it may have been an overreaction for two stocks.
Genomic Health
GHDX
GHDX
$54.35
$0.06
0.1%
BATS BZX Real Time Price as of June 19, 2019, 12:42 p.m.
View Interactive GHDX Charts
Genomic Health's diagnostic tests offer innovative cancer screening.
News & Analysis: Genomic Health
The Fool has written over 100 articles on Genomic Health.
3 Cancer Treatment Stocks to Buy Right Now
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
The 1 Stock I'd Buy Right Now
The genetic testing industry is still in its infancy, but this leader is comfortably profitable and growing at a healthy clip.
Genomic Health's Strong Growth Spooks Investors
A good start to the year and no increased guidance mean slower growth ahead.
Here's Why Shares of Genomic Health Dropped Today
After Genomic's stellar first quarter, investors are getting jittery about growth in the second half.
Genomic Health Inc (GHDX) Q1 2019 Earnings Call Transcript
GHDX earnings call for the period ending March 31, 2019.
Top Gene-Sequencing Stocks for 2019
These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
3 High-Growth Stocks That Are Just Getting Started
Find out how these companies have positioned themselves for bigger gains.
Genomic Health Continues Its Profitable Ways
The cancer test maker is growing earnings much faster than revenue.
Genomic Health, Inc. (GHDX) Q4 2018 Earnings Conference Call Transcript
GHDX earnings call for the period ending December 31, 2018.
